Skip to main content
Caplight Logo









Cryosa

Cryosa

Private
Arden Hills, MinnesotaHealthcare & Life Scienceshttps://cryosa.com/

Last Round

Series B

Sep 23, 2021

Total Funding Raised

$34.25M

Company Overview

Cryosa is a clinical-stage medical device company developing a minimally invasive, incisionless treatment for moderate to severe Obstructive Sleep Apnea (OSA).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

OSAobstructive sleep apneaneurostimulationsleep apnea implantimplantable medical deviceCPAP alternativehypoglossal nerve stimulationsleep apnea treatmentminimally invasive surgerymedical deviceclinical-stage medtechairway patencysleep medicineclinical trialsotolaryngology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cryosa Comparables

Compare Cryosa with similar companies based on industry and business-model similarity.

Cryosa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
XII Medical
91%
Lunair Medical
89%
Nyxoah
84%

Cryosa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 23, 2021
Series A ExtensionJun 25, 2020
Series AMay 29, 2019
Series AApr 20, 2018

Key People

Founding team and executive leadership

Donald Gonzales

Founder, CMO and Director

Founding Team

Laura Stoltenberg

Chief Executive Officer

Executive Team

Cryosa Investors

Notable investors and investment history

Cryosa investors
InvestorRounds
Santé VenturesSeries B, Series A Extension
Santé VenturesSeries B, Series A, Series A Extension
Solas BioVenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2021

    $22M round led by Solas BioVentures.

  • Jun 25, 2020

    $8.25M round led by Santé Ventures and HOYA Corporation.

Cryosa Filings

Explore SEC and related filing metadata, where available.

Cryosa filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cryosa's valuation, stock price, and market status.

Is Cryosa a public or private company?

Cryosa is a private company.

What is the current stock price of Cryosa?

Cryosa is a private company with no public stock price. No recent secondary market data is available.

How much is Cryosa worth (valuation)?

Valuation information for Cryosa is not publicly available.

Can I buy Cryosa stock?

Cryosa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cryosa's last funding round?

Cryosa's most recent funding round was Series B on September 23, 2021.

Who are the main investors in Cryosa?

Key investors in Cryosa include Santé Ventures, Solas BioVentures.

Will Cryosa IPO soon?

No public IPO plans have been announced for Cryosa.

How can I track Cryosa secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cryosa's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersArden Hills, Minnesota
Employee Range13
Year Founded2014
Last FundingSep 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?